SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Optimization of cognitive assessment in Parkinsonisms by applying artificial intelligence to a comprehensive screening test.

Ortelli, P; Ferrazzoli, D; Versace, V; Cian, V; Zarucchi, M; Gusmeroli, A; Canesi, M; Frazzitta, G; Volpe, D; Ricciardi, L; et al. Ortelli, P; Ferrazzoli, D; Versace, V; Cian, V; Zarucchi, M; Gusmeroli, A; Canesi, M; Frazzitta, G; Volpe, D; Ricciardi, L; Nardone, R; Ruffini, I; Saltuari, L; Sebastianelli, L; Baranzini, D; Maestri, R (2022) Optimization of cognitive assessment in Parkinsonisms by applying artificial intelligence to a comprehensive screening test. NPJ Parkinsons Dis, 8 (1). p. 42. ISSN 2373-8057 https://doi.org/10.1038/s41531-022-00304-z
SGUL Authors: Ricciardi, Lucia

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (641kB) | Preview
[img] Microsoft Word (.docx) (Supplementary tables) Published Version
Available under License Creative Commons Attribution.

Download (33kB)

Abstract

The assessment of cognitive deficits is pivotal for diagnosis and management in patients with parkinsonisms. Low levels of correspondence are observed between evaluations assessed with screening cognitive tests in comparison with those assessed with in-depth neuropsychological batteries. A new tool, we named CoMDA (Cognition in Movement Disorders Assessment), was composed by merging Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and Frontal Assessment Battery (FAB). In total, 500 patients (400 with Parkinson's disease, 41 with vascular parkinsonism, 31 with progressive supranuclear palsy, and 28 with multiple system atrophy) underwent CoMDA (level 1-L1) and in-depth neuropsychological battery (level 2-L2). Machine learning was developed to classify the CoMDA score and obtain an accurate prediction of the cognitive profile along three different classes: normal cognition (NC), mild cognitive impairment (MCI), and impaired cognition (IC). The classification accuracy of CoMDA, assessed by ROC analysis, was compared with MMSE, MoCA, and FAB. The area under the curve (AUC) of CoMDA was significantly higher than that of MMSE, MoCA and FAB (p < 0.0001, p = 0.028 and p = 0.0007, respectively). Among 15 different algorithmic methods, the Quadratic Discriminant Analysis algorithm (CoMDA-ML) showed higher overall-metrics performance levels in predictive performance. Considering L2 as a 3-level continuous feature, CoMDA-ML produces accurate and generalizable classifications: micro-average ROC curve, AUC = 0.81; and AUC = 0.85 for NC, 0.67 for MCI, and 0.83 for IC. CoMDA and COMDA-ML are reliable and time-sparing tools, accurate in classifying cognitive profile in parkinsonisms.This study has been registered on ClinicalTrials.gov (NCT04858893).

Item Type: Article
Additional Information: Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. © The Author(s) 2022
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: NPJ Parkinsons Dis
ISSN: 2373-8057
Language: eng
Dates:
DateEvent
11 April 2022Published
14 March 2022Accepted
Publisher License: Creative Commons: Attribution 4.0
PubMed ID: 35410449
Web of Science ID: WOS:000780921800002
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114358
Publisher's version: https://doi.org/10.1038/s41531-022-00304-z

Actions (login required)

Edit Item Edit Item